These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1837 related articles for article (PubMed ID: 26062653)

  • 1. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
    J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
    Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
    PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.
    Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP
    Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
    Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
    J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
    Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.
    Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL
    Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.